Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IGM-2644 |
Synonyms | |
Therapy Description |
IGM-2644 is a bispecific IgM T cell engager that targets CD38 and CD3, potentially resulting in complement-dependent cytotoxicity against tumor cells and inhibition of tumor growth (Blood (2022) 140 (Supplement 1): 6010-6011). |